Prolira Appoints Dominic Spadafore as Chief Executive Officer
Seasoned medtech executive with over two decades of industry experience and a proven track record of successfully commercializing disruptive medical technologies.
UTRECHT, The Netherlands, March 9, 2023 – Prolira BV, a high-tech company focused on early detection of acute brain failure to improve patient outcomes, has appointed Dominic J. Spadafore as its new Chief Executive Offer (CEO). Mr. Spadafore’s appointment comes at a critical stage for the company as it builds on its success in Europe and prepares for the US market release of its first commercial product, the DeltaScan® Brain State Monitor, for detecting acute brain failure. In his new role, Mr. Spadafore will be responsible for setting Prolira’s strategic direction, leading the US commercialization efforts for DeltaScan, supporting continued growth in key European markets and identifying strategic partners.